These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 5897861)

  • 21. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 22. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.
    Quy HT; Cobelens FG; Lan NT; Buu TN; Lambregts CS; Borgdorff MW
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):45-51. PubMed ID: 16466036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controlled intermittent treatment of newly detected patients with limited forms of tuberculosis of the lungs without destruction].
    Shmelev NA; Alabina MG; Afanasieva IuP; Maliutina TD; Kharchenko AK
    Ter Arkh; 1972 Aug; 44(8):55-8. PubMed ID: 5071585
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

  • 30. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 31. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous hormono-chemotherapy of pulmonary tuberculosis in case of drug-resistant mycobacteria].
    Repin IuM; Saburenkova EP
    Vrach Delo; 1969 Feb; 2():61-3. PubMed ID: 4305290
    [No Abstract]   [Full Text] [Related]  

  • 33. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN
    Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary drug resistance to standard drugs in previously untreated patients with pulmonary tuberculosis in Poznań in 1966-1969].
    Krzyzaniak J; Lubieńska B
    Gruzlica; 1971 Aug; 39(8):742-6. PubMed ID: 5097535
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
    Gómez Marín JE; Rigouts L; Villegas Londoño LE; Portaels F
    Bol Oficina Sanit Panam; 1995 Jul; 119(1):1-10. PubMed ID: 7654295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Practical tuberculostatic therapy].
    Hudson LD; Sbarbaro JA
    Fortschr Med; 1973 Nov; 91(32):1288. PubMed ID: 4751360
    [No Abstract]   [Full Text] [Related]  

  • 40. [Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1984 Mar; 112(3):290-5. PubMed ID: 6473971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.